Sunday, Sep 20, 2020
Focus on the big picture

Oxford Biomedica CEO on Covid-19 Vaccine, Industry Outlook

Bloomberg, 17 Sep 2020
Sep.17 -- John Dawson, chief executive officer at Oxford Biomedica Plc., discusses the manufacturing of a potential vaccine for covid-19, the company's part in ...
Related Articles